193 related articles for article (PubMed ID: 34837434)
1. Pseudoexon activation in disease by non-splice site deep intronic sequence variation - wild type pseudoexons constitute high-risk sites in the human genome.
Petersen USS; Doktor TK; Andresen BS
Hum Mutat; 2022 Feb; 43(2):103-127. PubMed ID: 34837434
[TBL] [Abstract][Full Text] [Related]
2. Antisense Oligonucleotide Rescue of Deep-Intronic Variants Activating Pseudoexons in the 6-Pyruvoyl-Tetrahydropterin Synthase Gene.
Martínez-Pizarro A; Leal F; Holm LL; Doktor TK; Petersen USS; Bueno M; Thöny B; Pérez B; Andresen BS; Desviat LR
Nucleic Acid Ther; 2022 Oct; 32(5):378-390. PubMed ID: 35833796
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing.
Keegan NP; Wilton SD; Fletcher S
Front Genet; 2021; 12():806946. PubMed ID: 35140743
[TBL] [Abstract][Full Text] [Related]
4. The deep intronic c.903+469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria.
Homolova K; Zavadakova P; Doktor TK; Schroeder LD; Kozich V; Andresen BS
Hum Mutat; 2010 Apr; 31(4):437-44. PubMed ID: 20120036
[TBL] [Abstract][Full Text] [Related]
5. Detailed molecular characterization of a novel IDS exonic mutation associated with multiple pseudoexon activation.
Grodecká L; Kováčová T; Kramárek M; Seneca S; Stouffs K; De Laet C; Majer F; Kršjaková T; Hujová P; Hrnčířová K; Souček P; Lissens W; Buratti E; Freiberger T
J Mol Med (Berl); 2017 Mar; 95(3):299-309. PubMed ID: 27837218
[TBL] [Abstract][Full Text] [Related]
6. Identification and Rescue of Splice Defects Caused by Two Neighboring Deep-Intronic ABCA4 Mutations Underlying Stargardt Disease.
Albert S; Garanto A; Sangermano R; Khan M; Bax NM; Hoyng CB; Zernant J; Lee W; Allikmets R; Collin RWJ; Cremers FPM
Am J Hum Genet; 2018 Apr; 102(4):517-527. PubMed ID: 29526278
[TBL] [Abstract][Full Text] [Related]
7. Multiple splicing defects in an intronic false exon.
Sun H; Chasin LA
Mol Cell Biol; 2000 Sep; 20(17):6414-25. PubMed ID: 10938119
[TBL] [Abstract][Full Text] [Related]
8. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
[TBL] [Abstract][Full Text] [Related]
9. The prevalent deep intronic c. 639+919 G>A GLA mutation causes pseudoexon activation and Fabry disease by abolishing the binding of hnRNPA1 and hnRNP A2/B1 to a splicing silencer.
Palhais B; Dembic M; Sabaratnam R; Nielsen KS; Doktor TK; Bruun GH; Andresen BS
Mol Genet Metab; 2016 Nov; 119(3):258-269. PubMed ID: 27595546
[TBL] [Abstract][Full Text] [Related]
10. The intronic splicing code: multiple factors involved in ATM pseudoexon definition.
Dhir A; Buratti E; van Santen MA; Lührmann R; Baralle FE
EMBO J; 2010 Feb; 29(4):749-60. PubMed ID: 20094034
[TBL] [Abstract][Full Text] [Related]
11. Disease-causing mutations improving the branch site and polypyrimidine tract: pseudoexon activation of LINE-2 and antisense Alu lacking the poly(T)-tail.
Meili D; Kralovicova J; Zagalak J; Bonafé L; Fiori L; Blau N; Thöny B; Vorechovsky I
Hum Mutat; 2009 May; 30(5):823-31. PubMed ID: 19280650
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics of
Weisschuh N; Mazzola P; Bertrand M; Haack TB; Wissinger B; Kohl S; Stingl K
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065499
[TBL] [Abstract][Full Text] [Related]
13. Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon Activation.
Hujová P; Souček P; Grodecká L; Grombiříková H; Ravčuková B; Kuklínek P; Hakl R; Litzman J; Freiberger T
J Clin Immunol; 2020 Apr; 40(3):435-446. PubMed ID: 31982983
[TBL] [Abstract][Full Text] [Related]
14. Global identification of hnRNP A1 binding sites for SSO-based splicing modulation.
Bruun GH; Doktor TK; Borch-Jensen J; Masuda A; Krainer AR; Ohno K; Andresen BS
BMC Biol; 2016 Jul; 14():54. PubMed ID: 27380775
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive characterisation of intronic mis-splicing mutations in human cancers.
Jung H; Lee KS; Choi JK
Oncogene; 2021 Feb; 40(7):1347-1361. PubMed ID: 33420369
[TBL] [Abstract][Full Text] [Related]
16. RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events.
Buratti E; Dhir A; Lewandowska MA; Baralle FE
Nucleic Acids Res; 2007; 35(13):4369-83. PubMed ID: 17580311
[TBL] [Abstract][Full Text] [Related]
17. Pre-spliceosomal binding of U1 small nuclear ribonucleoprotein (RNP) and heterogenous nuclear RNP E1 is associated with suppression of a growth hormone receptor pseudoexon.
Akker SA; Misra S; Aslam S; Morgan EL; Smith PJ; Khoo B; Chew SL
Mol Endocrinol; 2007 Oct; 21(10):2529-40. PubMed ID: 17622584
[TBL] [Abstract][Full Text] [Related]
18. Silencer elements as possible inhibitors of pseudoexon splicing.
Sironi M; Menozzi G; Riva L; Cagliani R; Comi GP; Bresolin N; Giorda R; Pozzoli U
Nucleic Acids Res; 2004; 32(5):1783-91. PubMed ID: 15034146
[TBL] [Abstract][Full Text] [Related]
19. Fine characterization of the recurrent c.1584+18672A>G deep-intronic mutation in the cystic fibrosis transmembrane conductance regulator gene.
Costantino L; Rusconi D; Soldà G; Seia M; Paracchini V; Porcaro L; Asselta R; Colombo C; Duga S
Am J Respir Cell Mol Biol; 2013 May; 48(5):619-25. PubMed ID: 23349053
[TBL] [Abstract][Full Text] [Related]
20. Screening of
Montalban G; Bonache S; Moles-Fernández A; Gisbert-Beamud A; Tenés A; Bach V; Carrasco E; López-Fernández A; Stjepanovic N; Balmaña J; Diez O; Gutiérrez-Enríquez S
J Med Genet; 2019 Feb; 56(2):63-74. PubMed ID: 30472649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
